ASLAN Pharmaceuticals
Signal active
Organization
Contact Information
Overview
ASLAN is a pharmaceutical company that develops novel medicines for global markets. It specializes in clinical-stage immunology and oncology-focused biopharmaceuticals.
About
Industries
Biotechnology, Health Care, Pharmaceutical, Medical, Oncology
Founded
2010
Employees
11-50
Headquarters locations
Asia
Social
N/A
Profile Resume
ASLAN Pharmaceuticals headquartered in Asia, operates in the Biotechnology, Health Care, Pharmaceutical, Medical, Oncology sector. The company focuses on Biotechnology and has secured $37.2B in funding across 200 round(s). With a team of 11-50 employees, ASLAN Pharmaceuticals is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - ASLAN Pharmaceuticals, raised $12.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
10
Investors
1
Lead Investors
0
Total Funding Amount
$186.0M
Details
5
ASLAN Pharmaceuticals has raised a total of $186.0M in funding over 5 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2016 | Late Stage Venture | 9.0M | ||
| 2015 | Late Stage Venture | 34.0M | ||
| 2013 | Early Stage Venture | 22.0M | ||
| 2011 | Early Stage Venture | 12.0M |
Investors
ASLAN Pharmaceuticals is funded by 28 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Morningside Group | - | FUNDING ROUND - Morningside Group | 22.0M |
| BioVeda Capital | - | FUNDING ROUND - BioVeda Capital | 22.0M |
| ASLAN Pharmaceuticals | - | FUNDING ROUND - ASLAN Pharmaceuticals | 22.0M |
| Sagamore Bioventures | - | FUNDING ROUND - Sagamore Bioventures | 22.0M |
Recent Activity
There is no recent news or activity for this profile.